Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001644956-25-000049
Filing Date
2025-11-12
Accepted
2025-11-12 18:08:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4814
  Complete submission text file 0001644956-25-000049.txt   6558
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Subject) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-83043 | Film No.: 251474651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 150 NORTH RIVERSIDE PLAZA CHICAGO IL 60606
Business Address 150 NORTH RIVERSIDE PLAZA CHICAGO IL 60606 312-236-1600
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by) CIK: 0001644956 (see all company filings)

EIN.: 472614791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G